Ryan Smolkin

Ryan Smolkin

Auto-generated profile, based on publicly available information

Ryan Smolkin

Gerstner Sloan Kettering Graduate School of Biomedical Sciences , New York, NY

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 October 2022 in Cancer Discovery
Verified
Journal Article
Open access
PDF file
HCHsuan-An Chen
Hsuan-An Chen
YHYu-Jui Ho
Yu-Jui Ho
RMRiccardo Mezzadra
Riccardo Mezzadra
JAJose M. Adrover
Jose M. Adrover
RSRyan Smolkin
Ryan Smolkin
SLScott W. Lowe
Scott W. Lowe
Cellular senescence involves a stable cell-cycle arrest coupled to a secretory program that, in some instances, stimulates the immune clearance of senescent cells. Using an immune-competent liver cancer model in which senescence triggers CD8 T cell–mediated tumor rejection, we show that senescence also remodels the cell-surface proteome to alter how tumor cells sense environmental factors, as exemplified by type II interferon (IFNγ). Compared with proliferating cells, senescent cells upregulate the IFNγ receptor, become hypersensitized to microenvironmental IFNγ, and more robustly induce the antigen-presenting machinery—effects also recapitulated in human tumor cells undergoing therapy-induced senescence. Disruption of IFNγ sensing in senescent cells blunts their immune-mediated clearance without disabling the senescence state or its characteristic secretory program. Our results demonstrate that senescent cells have an enhanced ability to both send and receive environmental signals and imply that each process is required for their effective immune surveillance. Significance: Our work uncovers an interplay between tissue remodeling and tissue-sensing programs that can be engaged by senescence in advanced cancers to render tumor cells more visible to the adaptive immune system. This new facet of senescence establishes reciprocal heterotypic signaling interactions that can be induced therapeutically to enhance antitumor immunity. See the interview with Direna Alonso-Curbelo, PhD, recipient of the inaugural Cancer Discovery Early Career Award: https://vimeo.com/992987447 See related article by Marin et al., p. 410. This article is highlighted in the In This Issue feature, p. 247

26 June 2023 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
RSRahul Sharma
Rahul Sharma
RSRyan M. Smolkin
Ryan M. Smolkin
PCPriyanka Chowdhury
Priyanka Chowdhury
KFKeith Conrad Fernandez
Keith Conrad Fernandez
YKYoungjun Kim
Youngjun Kim
JCJayanta Chaudhuri
Jayanta Chaudhuri

1 November 2021 in Cell Reports
Verified
Journal Article
Open access
WYWilliam T. Yewdell
William T. Yewdell
RSRyan M. Smolkin
Ryan M. Smolkin
KBKalina T. Belcheva
Kalina T. Belcheva
AMAlejandra Mendoza
Alejandra Mendoza
AMAnthony J. Michaels
Anthony J. Michaels
JCJayanta Chaudhuri
Jayanta Chaudhuri
Following infection or immunization, memory B cells (MBCs) and long-lived plasma cells provide humoral immunity that can last for decades. Most principles of MBC biology have been determined with hapten-protein carrier models or fluorescent protein immunizations. Here, we examine the temporal dynamics of the germinal center (GC) B cell and MBC response following mouse influenza A virus infection. We find that antiviral B cell responses within the lung-draining mediastinal lymph node (mLN) and the spleen are distinct in regard to duration, enrichment for antigen-binding cells, and class switching dynamics. While splenic GCs dissolve after 6 weeks post-infection, mLN hemagglutinin-specific (HA+) GCs can persist for 22 weeks. Persistent GCs continuously differentiate MBCs, with “peak” and “late” GCs contributing equal numbers of HA+ MBCs to the long-lived compartment. Our findings highlight critical aspects of persistent GC responses and MBC differentiation following respiratory virus infection with direct implications for developing effective vaccination strategies.

17 March 2025 in The Journal of Immunology
Verified
Journal Article
Closed access
PCPriyanka Chowdhury
Priyanka Chowdhury
KBKalina T Belcheva
Kalina T Belcheva
RSRyan M Smolkin
Ryan M Smolkin
MCMontserrat Cols
Montserrat Cols
JFJason D Fontenot
Jason D Fontenot
JCJayanta Chaudhuri
Jayanta Chaudhuri
The cytokine IL-2 plays a pivotal role in the immune system, specifically in the proliferation of T, B, and NK cells. The alpha subunit of the IL-2 receptor, IL-2Rα (CD25), is known to regulate the expansion and differentiation of T lymphocytes. CD25 is also expressed in developing B cells; however, its B cell intrinsic role remains undefined. We generated a mouse model with a B cell-specific deletion of CD25 to ascertain its role in B cell development and function. Unexpectedly, we found that the loss of CD25 had no impact on B cell development, homeostasis, or immune response to model antigens. Additionally, while CD25 expression was upregulated in activated splenic B cells, its absence did not affect class switch recombination in vitro or in vivo. We conclude that in contrast to its critical role in T cell differentiation and function, and despite its expression in developing and activated B cells, CD25 does not have any significant role in B cell development and adaptive immune functions.

4 April 2023
Verified
Other
Open access
HCHsuan-An Chen
Hsuan-An Chen
YHYu-Jui Ho
Yu-Jui Ho
RMRiccardo Mezzadra
Riccardo Mezzadra
JAJose M. Adrover
Jose M. Adrover
RSRyan Smolkin
Ryan Smolkin
SLScott W. Lowe
Scott W. Lowe
Supplementary Video S1 from Senescence Rewires Microenvironment Sensing to Facilitate Antitumor Immunity

7 August 2024
Verified
Other
Open access
HCHsuan-An Chen
Hsuan-An Chen
YHYu-Jui Ho
Yu-Jui Ho
RMRiccardo Mezzadra
Riccardo Mezzadra
JAJose M. Adrover
Jose M. Adrover
RSRyan Smolkin
Ryan Smolkin
SLScott W. Lowe
Scott W. Lowe
Supplementary Video S2 from Senescence Rewires Microenvironment Sensing to Facilitate Antitumor Immunity